SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Statement Re: Press Comment

20 Nov 2008 15:32

RNS Number : 6088I
Marwyn Materials Limited
20 November 2008
 



Marwyn Materials Limited ("Marwyn Materials")

STATEMENT REGARDING 

Ennstone PLC ("Ennstone")

Further to recent speculation, Marwyn Materials confirms that it has made an approach to the board of Ennstone in order to explore a possible transaction which may or may not be an offer. 

Shareholders should be aware that there is no certainty that any transaction will occur and a further announcement will be made as and when appropriate.

For the purposes of Rule 2.10 of the City Code on Takeovers and Mergers, Marwyn Materials confirms that it has 136,000,000 ordinary shares of no par value in issue at the close of business on 19 November 2008. The ISIN reference for these securities is JE00B2419D89.

Enquiries:

For further information, please contact:

Marwyn Materials Limited

Peter Tom

020 7389 6800

Simon Vivian

020 7389 6800

Collins Stewart Europe Limited (Nominated Adviser)

Stewart Wallace, Lorraine Delannoy

020 7523 8350

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Marwyn Materials or of Ennstone all dealings in any relevant securities of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Marwyn Materials or of Ennstone, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Marwyn Materials or of Ennstone by Marwyn Materials or Ennstone, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCFGMZMKGGGRZM
Date   Source Headline
17th Jul 202512:37 pmRNS-RNotice of live interactive presentation on Engage
30th Jun 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSBlock Listing Six Monthly Return
27th Jun 20254:10 pmRNSHolding(s) in Company
24th Jun 20251:00 pmRNSNotice of Interim Results
16th Jun 20254:42 pmRNSDirector/PDMR Shareholding
30th May 20259:41 amRNSTotal Voting Rights
6th May 20252:15 pmRNSHolding(s) in Company
2nd May 20253:34 pmRNSDirector/PDMR Shareholding
30th Apr 202512:46 pmRNSTotal Voting Rights
29th Apr 20254:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Trading Update
17th Apr 20253:24 pmRNSHolding(s) in Company
15th Apr 20251:27 pmRNSDirector/PDMR Shareholding
15th Apr 20259:25 amRNSHolding(s) in Company
15th Apr 20259:23 amRNSHolding(s) in Company
9th Apr 20253:31 pmRNSHolding(s) in Company
8th Apr 20255:16 pmRNSDirector/PDMR Shareholding
8th Apr 20255:15 pmRNSDirector/PDMR Shareholding
31st Mar 20253:23 pmRNSTotal Voting Rights
26th Mar 20252:34 pmRNSHolding(s) in Company
17th Mar 202510:10 amRNS2024 Annual Report and Notice of AGM
12th Mar 20253:35 pmRNSApplication for Admission of Consideration Shares
7th Mar 20257:00 amRNS-RLive presentation via Investor Meet Company
6th Mar 202512:00 pmRNSCompletion of Acquisition
5th Mar 20257:01 amRNSAcquisition
5th Mar 20257:00 amRNSFinal Results
28th Feb 20251:56 pmRNSTotal Voting Rights
4th Feb 20259:25 amRNSNotice of Results
31st Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSBlock listing six monthly return
31st Dec 20247:00 amRNSTotal Voting Rights
2nd Dec 20244:40 pmRNSDirector/PDMR Shareholding
29th Nov 20249:15 amRNSTotal Voting Rights
21st Nov 20247:00 amRNSNovember Trading Statement
12th Nov 20245:06 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20241:55 pmRNSTotal Voting Rights
30th Aug 20248:49 amRNSTotal Voting Rights
31st Jul 202410:11 amRNSTotal Voting Rights
24th Jul 20247:00 amRNSInterim results 2024
11th Jul 20244:33 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSBlock listing six monthly return
28th Jun 20247:00 amRNSTotal Voting Rights
25th Jun 20242:38 pmRNSNotice of Results
13th Jun 20243:53 pmRNSDirector/PDMR Shareholding
12th Jun 20245:16 pmRNSHolding(s) in Company
12th Jun 20244:31 pmRNSDirector/PDMR Shareholding
11th Jun 20244:28 pmRNSHolding(s) in Company
6th Jun 20242:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.